Decentralizing cell therapy delivery for broader patient access

As cell therapies scale toward broader indications and geographies, traditional centralized delivery models often create bottlenecks. This session explores practical strategies for decentralizing distribution, coordinating stakeholders, and ensuring that quality, chain of identity, and chain of custody remain intact as access grows.

Key takeaways:

• Map the operational requirements for decentralized cell therapy delivery
• Evaluate supply chain models that support regional or point-of-care manufacturing
• Define quality, traceability, and compliance needs in distributed networks
• Identify process improvements that reduce delays and access disparities
• Assess technology enablers that strengthen logistics and data flow